News: Biogen Idec

  • Day Trading Home
  • News
  • Live from the Blogosphere
  • In Forums
  • Hot off the Press
  • Blog
At a glance  |  Popular Tags  |  Related Tags

Biogen Idec

Biogen Idec, Inc. () is an American biotechnology company specializing in drugs for neurological disorders, autoimmune disorders and cancer.

Biogen IdecNatalizumabInterferon beta-1aHoward BirndorfIDECCambridge, MassachusettsRituximabÉlanJames L. VincentIvor RoystonSamsungCDP323East Cambridge, MassachusettsMIT150OcrelizumabDexpramipexoleRichard C. MulliganVolociximabSylvie GregoireKendall Square
Corporate Venture CapitalFine chemicalCONNECT (Organization)Ibritumomab tiuxetanGenetics Institute, Inc.Seth LedermanIndex of biotechnology articlesGaliximabPrize4LifeBill Valentine (architect)Myelin Repair FoundationLixivaptanNorth Carolina Science FestivalResearch Triangle ParkList of biotechnology companiesGeorgetown Preparatory SchoolAaron E. MillerList of drugs: ZList of recombinant proteinsDimethyl fumarate

Navigation

  • Day Trading Home
  • News
  • Live from the Blogosphere
  • In Forums
  • Hot off the Press
  • Blog
  • Podcasts
  • Videos
  • Best Sellers

Sponsors



Find news



Share this!

Our Services

Do not forget to check the lastest products and auctions related to Biogen Idec as well as our free videos and podcasts.

best Biogen Idec products current Biogen Idec auctions current Biogen Idec videos listen to Biogen Idec podcasts

This Day In History

©2012 Firstname Lastname      Design by: styleshout

Day Trading Home | Privacy | Terms of use